Found: 21
Select item for more details and to access through your institution.
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65689-8
- By:
- Publication type:
- Article
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63172-y
- By:
- Publication type:
- Article
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.
- Published in:
- Medical Science Monitor, 2017, v. 23, p. 4028, doi. 10.12659/MSM.902576
- By:
- Publication type:
- Article
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 495, doi. 10.1007/s10147-024-02493-4
- By:
- Publication type:
- Article
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1073, doi. 10.1007/s10147-023-02354-6
- By:
- Publication type:
- Article
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 941, doi. 10.1007/s10147-021-01859-2
- By:
- Publication type:
- Article
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
- Published in:
- Oncology, 2023, v. 101, n. 1, p. 22, doi. 10.1159/000527176
- By:
- Publication type:
- Article
Safe Performance of Track Dilation and Bile Aspiration with ERCP Catheter in EUS-Guided Hepaticogastrostomy with Plastic Stents: A Retrospective Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 4986, doi. 10.3390/jcm11174986
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46924-0
- By:
- Publication type:
- Article
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34962-7
- By:
- Publication type:
- Article
Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1234113
- By:
- Publication type:
- Article
Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1195, doi. 10.3390/diagnostics11071195
- By:
- Publication type:
- Article
Covered self-expandable metallic stents versus plastic stents for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction.
- Published in:
- Clinical Endoscopy, 2023, v. 56, n. 6, p. 802, doi. 10.5946/ce.2022.211
- By:
- Publication type:
- Article
Retracted: Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.
- Published in:
- Medical Science Monitor, 2018, v. 24, p. 1768, doi. 10.12659/MSM.909667
- By:
- Publication type:
- Article
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
- Published in:
- Cancer Science, 2024, v. 115, n. 5, p. 1622, doi. 10.1111/cas.16109
- By:
- Publication type:
- Article
Endoscopic Ultrasound-Guided Gallbladder Drainage for Aberrant Right Posterior Duct Obstruction Developing after Placement of a Covered Self-Expandable Metallic Stent in a Patient with Distal Biliary Obstruction.
- Published in:
- Case Reports in Gastroenterology, 2018, v. 12, n. 3, p. 722, doi. 10.1159/000492215
- By:
- Publication type:
- Article
Correction: Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02367-5
- By:
- Publication type:
- Article
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
- Published in:
- 2022
- By:
- Publication type:
- journal article